Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Reducing Disabilities in Alzheimer's Disease (RDAD) Translation in Area Agencies on Aging (AAAs)
From Evidence-Base to Practice: Implementing RDAD in AAA Community-Based Services
Status: Enrolling
Updated:  9/14/2017
Univ of Washington
mi
from
Seattle, WA
Reducing Disabilities in Alzheimer's Disease (RDAD) Translation in Area Agencies on Aging (AAAs)
From Evidence-Base to Practice: Implementing RDAD in AAA Community-Based Services
Status: Enrolling
Updated: 9/14/2017
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Teriflunomide's Therapeutic Mechanisms of Action in Patients With Relapsing Remitting Multiple Sclerosis.
Characterization of Teriflunomide's Therapeutic Mechanisms of Action in Patients With Relapsing Remitting Multiple Sclerosis.
Status: Enrolling
Updated:  9/14/2017
Univ of North Carolina
mi
from
Chapel Hill, NC
Teriflunomide's Therapeutic Mechanisms of Action in Patients With Relapsing Remitting Multiple Sclerosis.
Characterization of Teriflunomide's Therapeutic Mechanisms of Action in Patients With Relapsing Remitting Multiple Sclerosis.
Status: Enrolling
Updated: 9/14/2017
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Safety Tolerability and Efficacy Study of Cabaletta to Treat Oculopharyngeal Muscular Dystrophy (OPMD) Patients
Multi-Center, Dose-Escalation Study, to Assess Safety, Tolerability and Efficacy of Intravenous Cabaletta® in OPMD Patients
Status: Enrolling
Updated:  9/15/2017
UCLA
mi
from
Los Angeles, CA
Safety Tolerability and Efficacy Study of Cabaletta to Treat Oculopharyngeal Muscular Dystrophy (OPMD) Patients
Multi-Center, Dose-Escalation Study, to Assess Safety, Tolerability and Efficacy of Intravenous Cabaletta® in OPMD Patients
Status: Enrolling
Updated: 9/15/2017
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety Tolerability and Efficacy Study of Cabaletta to Treat Oculopharyngeal Muscular Dystrophy (OPMD) Patients
Multi-Center, Dose-Escalation Study, to Assess Safety, Tolerability and Efficacy of Intravenous Cabaletta® in OPMD Patients
Status: Enrolling
Updated:  9/15/2017
Tahseen Mozaffar
mi
from
Orange, CA
Safety Tolerability and Efficacy Study of Cabaletta to Treat Oculopharyngeal Muscular Dystrophy (OPMD) Patients
Multi-Center, Dose-Escalation Study, to Assess Safety, Tolerability and Efficacy of Intravenous Cabaletta® in OPMD Patients
Status: Enrolling
Updated: 9/15/2017
Tahseen Mozaffar
mi
from
Orange, CA
Click here to add this to my saved trials
Safety Tolerability and Efficacy Study of Cabaletta to Treat Oculopharyngeal Muscular Dystrophy (OPMD) Patients
Multi-Center, Dose-Escalation Study, to Assess Safety, Tolerability and Efficacy of Intravenous Cabaletta® in OPMD Patients
Status: Enrolling
Updated:  9/15/2017
Montreal Neurological Institute, McGill University
mi
from
Montreal,
Safety Tolerability and Efficacy Study of Cabaletta to Treat Oculopharyngeal Muscular Dystrophy (OPMD) Patients
Multi-Center, Dose-Escalation Study, to Assess Safety, Tolerability and Efficacy of Intravenous Cabaletta® in OPMD Patients
Status: Enrolling
Updated: 9/15/2017
Montreal Neurological Institute, McGill University
mi
from
Montreal,
Click here to add this to my saved trials
High Dose Omega-3 Fatty Acids in the Treatment of Sport Related Concussions
High Dose Omega-3 Fatty Acids in the Treatment of Sport Related Concussions
Status: Enrolling
Updated:  9/18/2017
East Carolina University
mi
from
Greenville, NC
High Dose Omega-3 Fatty Acids in the Treatment of Sport Related Concussions
High Dose Omega-3 Fatty Acids in the Treatment of Sport Related Concussions
Status: Enrolling
Updated: 9/18/2017
East Carolina University
mi
from
Greenville, NC
Click here to add this to my saved trials
A Clinical Study to Determine the Safety and Effectiveness of Dentinal Hypersensitivity Treatment With Two Different Toothbrushes
Status: Enrolling
Updated:  9/18/2017
Chad J Anderson DMD Inc
mi
from
Fresno, CA
A Clinical Study to Determine the Safety and Effectiveness of Dentinal Hypersensitivity Treatment With Two Different Toothbrushes
Status: Enrolling
Updated: 9/18/2017
Chad J Anderson DMD Inc
mi
from
Fresno, CA
Click here to add this to my saved trials
Helping Older Persons Emerge Stronger
Helping Older Persons Emerge Stronger (HOPES) After Intensive Care Unit Admission
Status: Enrolling
Updated:  9/18/2017
The Ohio State University College of Nursing
mi
from
Columbus, OH
Helping Older Persons Emerge Stronger
Helping Older Persons Emerge Stronger (HOPES) After Intensive Care Unit Admission
Status: Enrolling
Updated: 9/18/2017
The Ohio State University College of Nursing
mi
from
Columbus, OH
Click here to add this to my saved trials
First Time in Human Study of GSK1223249 in Amyotrophic Lateral Sclerosis
A Single and Repeat Dose Escalation Study of the Safety, Pharmacokinetics and Pharmacodynamics of GSK1223249 in ALS Patients
Status: Enrolling
Updated:  9/19/2017
GSK Investigational Site
mi
from
Baltimore, MD
First Time in Human Study of GSK1223249 in Amyotrophic Lateral Sclerosis
A Single and Repeat Dose Escalation Study of the Safety, Pharmacokinetics and Pharmacodynamics of GSK1223249 in ALS Patients
Status: Enrolling
Updated: 9/19/2017
GSK Investigational Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
First Time in Human Study of GSK1223249 in Amyotrophic Lateral Sclerosis
A Single and Repeat Dose Escalation Study of the Safety, Pharmacokinetics and Pharmacodynamics of GSK1223249 in ALS Patients
Status: Enrolling
Updated:  9/19/2017
GSK Investigational Site
mi
from
New York, NY
First Time in Human Study of GSK1223249 in Amyotrophic Lateral Sclerosis
A Single and Repeat Dose Escalation Study of the Safety, Pharmacokinetics and Pharmacodynamics of GSK1223249 in ALS Patients
Status: Enrolling
Updated: 9/19/2017
GSK Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
First Time in Human Study of GSK1223249 in Amyotrophic Lateral Sclerosis
A Single and Repeat Dose Escalation Study of the Safety, Pharmacokinetics and Pharmacodynamics of GSK1223249 in ALS Patients
Status: Enrolling
Updated:  9/19/2017
GSK Investigational Site
mi
from
Syracuse, NY
First Time in Human Study of GSK1223249 in Amyotrophic Lateral Sclerosis
A Single and Repeat Dose Escalation Study of the Safety, Pharmacokinetics and Pharmacodynamics of GSK1223249 in ALS Patients
Status: Enrolling
Updated: 9/19/2017
GSK Investigational Site
mi
from
Syracuse, NY
Click here to add this to my saved trials
First Time in Human Study of GSK1223249 in Amyotrophic Lateral Sclerosis
A Single and Repeat Dose Escalation Study of the Safety, Pharmacokinetics and Pharmacodynamics of GSK1223249 in ALS Patients
Status: Enrolling
Updated:  9/19/2017
GSK Investigational Site
mi
from
Charlotte, NC
First Time in Human Study of GSK1223249 in Amyotrophic Lateral Sclerosis
A Single and Repeat Dose Escalation Study of the Safety, Pharmacokinetics and Pharmacodynamics of GSK1223249 in ALS Patients
Status: Enrolling
Updated: 9/19/2017
GSK Investigational Site
mi
from
Charlotte, NC
Click here to add this to my saved trials
First Time in Human Study of GSK1223249 in Amyotrophic Lateral Sclerosis
A Single and Repeat Dose Escalation Study of the Safety, Pharmacokinetics and Pharmacodynamics of GSK1223249 in ALS Patients
Status: Enrolling
Updated:  9/19/2017
GSK Investigational Site
mi
from
Winston-Salem, NC
First Time in Human Study of GSK1223249 in Amyotrophic Lateral Sclerosis
A Single and Repeat Dose Escalation Study of the Safety, Pharmacokinetics and Pharmacodynamics of GSK1223249 in ALS Patients
Status: Enrolling
Updated: 9/19/2017
GSK Investigational Site
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
First Time in Human Study of GSK1223249 in Amyotrophic Lateral Sclerosis
A Single and Repeat Dose Escalation Study of the Safety, Pharmacokinetics and Pharmacodynamics of GSK1223249 in ALS Patients
Status: Enrolling
Updated:  9/19/2017
GSK Investigational Site
mi
from
Columbus, OH
First Time in Human Study of GSK1223249 in Amyotrophic Lateral Sclerosis
A Single and Repeat Dose Escalation Study of the Safety, Pharmacokinetics and Pharmacodynamics of GSK1223249 in ALS Patients
Status: Enrolling
Updated: 9/19/2017
GSK Investigational Site
mi
from
Columbus, OH
Click here to add this to my saved trials
First Time in Human Study of GSK1223249 in Amyotrophic Lateral Sclerosis
A Single and Repeat Dose Escalation Study of the Safety, Pharmacokinetics and Pharmacodynamics of GSK1223249 in ALS Patients
Status: Enrolling
Updated:  9/19/2017
GSK Investigational Site
mi
from
Paris,
First Time in Human Study of GSK1223249 in Amyotrophic Lateral Sclerosis
A Single and Repeat Dose Escalation Study of the Safety, Pharmacokinetics and Pharmacodynamics of GSK1223249 in ALS Patients
Status: Enrolling
Updated: 9/19/2017
GSK Investigational Site
mi
from
Paris,
Click here to add this to my saved trials
Neuroactive Steroids and Traumatic Brain Injury (TBI) in OEF/OIF Veterans
Neuroactive Steroids and TBI in OEF/OIF Veterans
Status: Enrolling
Updated:  9/19/2017
Durham VA Medical Center, Durham, NC
mi
from
Durham, NC
Neuroactive Steroids and Traumatic Brain Injury (TBI) in OEF/OIF Veterans
Neuroactive Steroids and TBI in OEF/OIF Veterans
Status: Enrolling
Updated: 9/19/2017
Durham VA Medical Center, Durham, NC
mi
from
Durham, NC
Click here to add this to my saved trials
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated:  9/19/2017
Mayo Clinic
mi
from
Phoenix, AZ
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated: 9/19/2017
Mayo Clinic
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated:  9/19/2017
Rancho Los Amigos National Rehabilitation Center
mi
from
Downey, CA
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated: 9/19/2017
Rancho Los Amigos National Rehabilitation Center
mi
from
Downey, CA
Click here to add this to my saved trials
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated:  9/19/2017
Shepherd Rehabilitation Center
mi
from
Atlanta, GA
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated: 9/19/2017
Shepherd Rehabilitation Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated:  9/19/2017
Rehabilitation Institute of Chicago
mi
from
Chicago, IL
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated: 9/19/2017
Rehabilitation Institute of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated:  9/19/2017
Indiana University Indianapolis
mi
from
Indianapolis, IN
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated: 9/19/2017
Indiana University Indianapolis
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated:  9/19/2017
Spaulding Rehabilitation Hospital
mi
from
Boston, MA
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated: 9/19/2017
Spaulding Rehabilitation Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated:  9/19/2017
Columbia Cornell New York Presbyterian Hospital
mi
from
New York, NY
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated: 9/19/2017
Columbia Cornell New York Presbyterian Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated:  9/19/2017
Burke Medical Research Institute, Weill Cornell Neurology
mi
from
White Plains, NY
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated: 9/19/2017
Burke Medical Research Institute, Weill Cornell Neurology
mi
from
White Plains, NY
Click here to add this to my saved trials
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated:  9/19/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated: 9/19/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated:  9/19/2017
University of Cincinnati
mi
from
Cincinnati, OH
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated: 9/19/2017
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated:  9/19/2017
Ohio State University
mi
from
Columbus, OH
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated: 9/19/2017
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated:  9/19/2017
TIRR Memorial Hermann Hospital
mi
from
Houston, TX
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Status: Enrolling
Updated: 9/19/2017
TIRR Memorial Hermann Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)
A Phase II Trial Of Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)
Status: Enrolling
Updated:  9/20/2017
Memoral Sloan Kettering Cancer Center
mi
from
Basking Ridge, NJ
Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)
A Phase II Trial Of Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)
Status: Enrolling
Updated: 9/20/2017
Memoral Sloan Kettering Cancer Center
mi
from
Basking Ridge, NJ
Click here to add this to my saved trials
Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)
A Phase II Trial Of Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)
Status: Enrolling
Updated:  9/20/2017
Memorial Sloan-Kettering Cancer Center @ Suffolk
mi
from
Commack, NY
Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)
A Phase II Trial Of Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)
Status: Enrolling
Updated: 9/20/2017
Memorial Sloan-Kettering Cancer Center @ Suffolk
mi
from
Commack, NY
Click here to add this to my saved trials
Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)
A Phase II Trial Of Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)
Status: Enrolling
Updated:  9/20/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)
A Phase II Trial Of Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)
Status: Enrolling
Updated: 9/20/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)
A Phase II Trial Of Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)
Status: Enrolling
Updated:  9/20/2017
Memorial Sloan Kettering West Harrison
mi
from
Harrison, NY
Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)
A Phase II Trial Of Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)
Status: Enrolling
Updated: 9/20/2017
Memorial Sloan Kettering West Harrison
mi
from
Harrison, NY
Click here to add this to my saved trials
A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD
A Phase III Clinical Endpoint Evaluation Study Examining the Safety and Efficacy of HLD200 in Pediatric Subjects With Attention-Deficit Hyperactivity Disorder.
Status: Enrolling
Updated:  9/20/2017
AVIDA, Inc.
mi
from
Newport Beach, CA
A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD
A Phase III Clinical Endpoint Evaluation Study Examining the Safety and Efficacy of HLD200 in Pediatric Subjects With Attention-Deficit Hyperactivity Disorder.
Status: Enrolling
Updated: 9/20/2017
AVIDA, Inc.
mi
from
Newport Beach, CA
Click here to add this to my saved trials
A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD
A Phase III Clinical Endpoint Evaluation Study Examining the Safety and Efficacy of HLD200 in Pediatric Subjects With Attention-Deficit Hyperactivity Disorder.
Status: Enrolling
Updated:  9/20/2017
South Shore Psychiatric Services, PC
mi
from
Marshfield, MA
A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD
A Phase III Clinical Endpoint Evaluation Study Examining the Safety and Efficacy of HLD200 in Pediatric Subjects With Attention-Deficit Hyperactivity Disorder.
Status: Enrolling
Updated: 9/20/2017
South Shore Psychiatric Services, PC
mi
from
Marshfield, MA
Click here to add this to my saved trials
A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD
A Phase III Clinical Endpoint Evaluation Study Examining the Safety and Efficacy of HLD200 in Pediatric Subjects With Attention-Deficit Hyperactivity Disorder.
Status: Enrolling
Updated:  9/20/2017
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD
A Phase III Clinical Endpoint Evaluation Study Examining the Safety and Efficacy of HLD200 in Pediatric Subjects With Attention-Deficit Hyperactivity Disorder.
Status: Enrolling
Updated: 9/20/2017
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD
A Phase III Clinical Endpoint Evaluation Study Examining the Safety and Efficacy of HLD200 in Pediatric Subjects With Attention-Deficit Hyperactivity Disorder.
Status: Enrolling
Updated:  9/20/2017
Duke Univ Med Ctr
mi
from
Durham, NC
A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD
A Phase III Clinical Endpoint Evaluation Study Examining the Safety and Efficacy of HLD200 in Pediatric Subjects With Attention-Deficit Hyperactivity Disorder.
Status: Enrolling
Updated: 9/20/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
A Trial of the Drug Donepezil for Sleep Enhancement and Behavioral Change in Children With Autism
A Randomized Controlled Trial of Donepezil for REM Enhancement and Behavioral Change in Autism
Status: Enrolling
Updated:  9/21/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
A Trial of the Drug Donepezil for Sleep Enhancement and Behavioral Change in Children With Autism
A Randomized Controlled Trial of Donepezil for REM Enhancement and Behavioral Change in Autism
Status: Enrolling
Updated: 9/21/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
An Evaluation of the Efficacy of Oral-B New Product Sensi-Stop on Dentinal Hypersensitivity
An Evaluation of the Efficacy of Oral-B New Product Sensi-Stop on Dentinal Hypersensitivity
Status: Enrolling
Updated:  9/21/2017
Oral Health Research Clinic at the School of Dentistry at the University of Minnesota
mi
from
Minneapolis, MN
An Evaluation of the Efficacy of Oral-B New Product Sensi-Stop on Dentinal Hypersensitivity
An Evaluation of the Efficacy of Oral-B New Product Sensi-Stop on Dentinal Hypersensitivity
Status: Enrolling
Updated: 9/21/2017
Oral Health Research Clinic at the School of Dentistry at the University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With RRMS
Open-Label, Multicenter, Multiple-Dose Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With Relapsing-Remitting Multiple Sclerosis Aged 10 to 17 Years
Status: Enrolling
Updated:  9/21/2017
mi
from
Gent,
Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With RRMS
Open-Label, Multicenter, Multiple-Dose Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With Relapsing-Remitting Multiple Sclerosis Aged 10 to 17 Years
Status: Enrolling
Updated: 9/21/2017
mi
from
Gent,
Click here to add this to my saved trials
Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With RRMS
Open-Label, Multicenter, Multiple-Dose Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With Relapsing-Remitting Multiple Sclerosis Aged 10 to 17 Years
Status: Enrolling
Updated:  9/21/2017
Clinical Research Facility
mi
from
San Bernardino, CA
Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With RRMS
Open-Label, Multicenter, Multiple-Dose Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With Relapsing-Remitting Multiple Sclerosis Aged 10 to 17 Years
Status: Enrolling
Updated: 9/21/2017
Clinical Research Facility
mi
from
San Bernardino, CA
Click here to add this to my saved trials
Evaluating Dietary Intervention Before surgicaL Treatment for Epilepsy
A Randomised Controlled Trial to Compare Seizure Remission Outcome Following Resective Surgery With or Without Prior Treatment With Ketogenic Diet in Children With Epilepsy the Result of Focal Cortical Dysplasia Type II
Status: Enrolling
Updated:  9/21/2017
Johns Hopkins Hospital
mi
from
Baltimore, MD
Evaluating Dietary Intervention Before surgicaL Treatment for Epilepsy
A Randomised Controlled Trial to Compare Seizure Remission Outcome Following Resective Surgery With or Without Prior Treatment With Ketogenic Diet in Children With Epilepsy the Result of Focal Cortical Dysplasia Type II
Status: Enrolling
Updated: 9/21/2017
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Evaluating Dietary Intervention Before surgicaL Treatment for Epilepsy
A Randomised Controlled Trial to Compare Seizure Remission Outcome Following Resective Surgery With or Without Prior Treatment With Ketogenic Diet in Children With Epilepsy the Result of Focal Cortical Dysplasia Type II
Status: Enrolling
Updated:  9/21/2017
Medical University of Vienna
mi
from
Vienna,
Evaluating Dietary Intervention Before surgicaL Treatment for Epilepsy
A Randomised Controlled Trial to Compare Seizure Remission Outcome Following Resective Surgery With or Without Prior Treatment With Ketogenic Diet in Children With Epilepsy the Result of Focal Cortical Dysplasia Type II
Status: Enrolling
Updated: 9/21/2017
Medical University of Vienna
mi
from
Vienna,
Click here to add this to my saved trials
Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis
Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis
Status: Enrolling
Updated:  9/22/2017
University of Chicago
mi
from
Chicago, IL
Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis
Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis
Status: Enrolling
Updated: 9/22/2017
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Ziprasidone vs Standard Therapy for Agitated Patients in the ED
Prospective Double Blind Randomized Trial of Intramuscular Ziprasidone Compared With Standard Antipsychotic Therapy For The Treatment Of The Acutely Agitated Patient In The Emergency Department
Status: Enrolling
Updated:  9/22/2017
The George Washington University Medical Center, Dept of Emergency Medicine
mi
from
Washington, D.C.,
Ziprasidone vs Standard Therapy for Agitated Patients in the ED
Prospective Double Blind Randomized Trial of Intramuscular Ziprasidone Compared With Standard Antipsychotic Therapy For The Treatment Of The Acutely Agitated Patient In The Emergency Department
Status: Enrolling
Updated: 9/22/2017
The George Washington University Medical Center, Dept of Emergency Medicine
mi
from
Washington, D.C.,
Click here to add this to my saved trials
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight (ELBW) Infants
Status: Enrolling
Updated:  9/22/2017
University of Alabama at Birmingham
mi
from
Birmingham, AL
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight (ELBW) Infants
Status: Enrolling
Updated: 9/22/2017
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight (ELBW) Infants
Status: Enrolling
Updated:  9/22/2017
Stanford University
mi
from
Palo Alto, CA
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight (ELBW) Infants
Status: Enrolling
Updated: 9/22/2017
Stanford University
mi
from
Palo Alto, CA
Click here to add this to my saved trials
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight (ELBW) Infants
Status: Enrolling
Updated:  9/22/2017
Yale University
mi
from
New Haven, CT
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight (ELBW) Infants
Status: Enrolling
Updated: 9/22/2017
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight (ELBW) Infants
Status: Enrolling
Updated:  9/22/2017
George Washington University
mi
from
Washington, D.C.,
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight (ELBW) Infants
Status: Enrolling
Updated: 9/22/2017
George Washington University
mi
from
Washington, D.C.,
Click here to add this to my saved trials
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight (ELBW) Infants
Status: Enrolling
Updated:  9/22/2017
University of Miami
mi
from
Miami, FL
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight (ELBW) Infants
Status: Enrolling
Updated: 9/22/2017
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight (ELBW) Infants
Status: Enrolling
Updated:  9/22/2017
Emory University
mi
from
Atlanta, GA
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight (ELBW) Infants
Status: Enrolling
Updated: 9/22/2017
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials